Thorny case for Arix chief to answer
Corporate deals throw up all sorts of governance questions. But here’s a simple one: should a chairman be more obviously independent before he recommends a transaction that discriminates against three
Stay updated with breaking news from Arix Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Corporate deals throw up all sorts of governance questions. But here’s a simple one: should a chairman be more obviously independent before he recommends a transaction that discriminates against three
The under-fire chairman of Arix Bioscience held a board meeting in the Caribbean, despite the investment company having no business interests in the region.Pe
Revenue Declines as Company Focuses on Asset Acquisitions and Capital Allocation
Investegate announcements from Correction: Portfolio Company Aura Biosciences Announces Closing of $99 million Public Offering of Common Stock
One of Arix Bioscience’s joint-brokers quit on the morning it announced a contentious takeover deal in protest at its inequitable treatment of shareholders. Pe